Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarantelli

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
Journal of Clinical Medicine|January 21, 2023
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK InhibitorsFrancesca Guidetti, Alberto J Arribas, Giulio Sartori, et al.
Cancer Medicine|May 14, 2026
Exploring Resistance to ETS Targeting Agents in Diffuse Large B-Cell LymphomaFilippo Spriano, Luciano Cascione, Chiara Tarantelli, et al.
La Clinica Terapeutica|March 12, 1998
[Use of ropivacaine in axillary brachial plexus block]F Fattorini, M A Pascarella, S G Benvenuti, et al.
Experimental Cell Research|June 29, 2014
Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomasGabriella Mincione, Chiara Tarantelli, Giovina Vianale, et al.
British Journal of Haematology|August 4, 2015
The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical modelsElena Bernasconi, Eugenio Gaudio, Ivo Kwee, et al.
Oncotarget|October 13, 2016
Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activityGabriella Mincione, Maria Carmela Di Marcantonio, Chiara Tarantelli, et al.
La Clinica Terapeutica|April 7, 1998
[Use of mivacurium in orthopedic surgery: comparison of 2 different-dose inductions]C Tarantelli, M A Pascarella, R Perna, et al.
Oncotarget|November 28, 2014
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphomaRosaria Chilà, Alessandra Basana, Monica Lupi, et al.
Hematological Oncology|March 5, 2025
Targeting of PIM Kinases Shows Single Agent Efficacy and Synergizes With BCL2 Inhibitors in Diffuse Large B Cell Lymphoma of the ABC SubtypeChiara Tarantelli, Omar Kayali, Elisa Civanelli, et al.
Oncotarget|August 6, 2016
Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphomaEugenio Gaudio, Chiara Tarantelli, Maurilio Ponzoni, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Journal of Clinical Medicine|January 21, 2023
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK InhibitorsFrancesca Guidetti, Alberto J Arribas, Giulio Sartori, et al.
Cancer Medicine|May 14, 2026
Exploring Resistance to ETS Targeting Agents in Diffuse Large B-Cell LymphomaFilippo Spriano, Luciano Cascione, Chiara Tarantelli, et al.
La Clinica Terapeutica|March 12, 1998
[Use of ropivacaine in axillary brachial plexus block]F Fattorini, M A Pascarella, S G Benvenuti, et al.
Experimental Cell Research|June 29, 2014
Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomasGabriella Mincione, Chiara Tarantelli, Giovina Vianale, et al.
British Journal of Haematology|August 4, 2015
The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical modelsElena Bernasconi, Eugenio Gaudio, Ivo Kwee, et al.
Oncotarget|October 13, 2016
Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activityGabriella Mincione, Maria Carmela Di Marcantonio, Chiara Tarantelli, et al.
La Clinica Terapeutica|April 7, 1998
[Use of mivacurium in orthopedic surgery: comparison of 2 different-dose inductions]C Tarantelli, M A Pascarella, R Perna, et al.
Oncotarget|November 28, 2014
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphomaRosaria Chilà, Alessandra Basana, Monica Lupi, et al.
Hematological Oncology|March 5, 2025
Targeting of PIM Kinases Shows Single Agent Efficacy and Synergizes With BCL2 Inhibitors in Diffuse Large B Cell Lymphoma of the ABC SubtypeChiara Tarantelli, Omar Kayali, Elisa Civanelli, et al.
Oncotarget|August 6, 2016
Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphomaEugenio Gaudio, Chiara Tarantelli, Maurilio Ponzoni, et al.
Pageof 18